| Registrars: | Equiniti |
| CFO: | Lachlan Smith |
| Chairman: | William D Brown |
| Independent Non-Executive Director: | John Louis Ely |
| Independent Non-Executive Director: | Ian Ardill |
| Independent Non-Executive Director: | Geoffrey Alan Berg |
| Non-Executive Dir: | John McKenna |
| Address: | 2 Drummond Crescent, Riverside Business Park, Irvine, Ayrshire, United Kingdom, KA11 5AN |
| Website: | http://rualifesciences.com/ |
| Sector: | Health Care(LSE) |
| Index: | FTSE AIM All-Share |
| ISIN: | GB0033360586 |
| Currency | UK Pounds |
| Share Price | 13.25p |
| Change Today | 0.25p |
| % Change | 1.92 % |
| 52 Week High | 13.60 |
| 52 Week Low | 10.50 |
| Volume | 102,952 |
| Shares Issued | 62.06m |
| Market Cap | £8.22m |
| Beta | 0.13 |
| RiskGrade | 290 |
| Value |
|
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth |
|
|---|
| No dividends found |
| Time | Volume / Share Price |
| 09:07 | 10,000 @ 13.13p |
| 09:00 | 18,496 @ 13.20p |
| 09:00 | 46 @ 13.20p |
| 09:00 | 18,450 @ 13.20p |
| 08:26 | 15,000 @ 13.43p |
| Chair | William D Brown |
| CFO | Lachlan Smith |
You are here: research